Table: Oncolys Biopharma -2024 parent results

Oncolys Biopharma

07/02/2025 06:01

Feb 7 (Reuters)- 
          Oncolys Biopharma Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended       Year ended       Year to       NEXT   
              Dec 31, 2024     Dec 31, 2023   Dec 31, 2025     YEAR     
                 LATEST          YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales          31 mln           63 mln                                
               (-50.2 pct)     (-93.5 pct)                              
  Operating     loss 1.68       loss 1.93                               
  Recurring     loss 1.66       loss 1.91                               
  Net           loss 1.68       loss 1.94                               
  EPS        loss 77.17 yen  loss 108.92 yen                            
  Ann Div          NIL             NIL             NIL                  
  -Q2 Div          NIL             NIL             NIL                  
  -Q4 Div          NIL             NIL             NIL                  
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T